Items where Author is "Pestalozzi, B. C."

2014

Matter-Walstra, K. M. and Achermann, R. and Rapold, R. and Klingbiel, D. and Bordoni, A. and Dehler, S. and Jundt, G. and Konzelmann, I. and Clough-Gorr, K. and Szucs, T. and Schwenkglenks, M. and Pestalozzi, B. C.. (2014) Delivery of health care at the end of life in cancer patients of four swiss cantons : a retrospective database study (SAKK 89/09). BMC cancer, Vol. 14. pp. 306-317.

Matter-Walstra, K. and Klingbiel, D. and Szucs, T. and Pestalozzi, B. C. and Schwenkglenks, M.. (2014) Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied? PharmacoEconomics, Vol. 32, no. 6. pp. 591-599.

2010

Riener, M. O. and Vogetseder, A. and Pestalozzi, B. C. and Clavien, P. A. and Probst-Hensch N., and Kristiansen, G. and Jochum, W.. (2010) Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Human pathology, Vol. 41, H. 11. pp. 1558-1565.

Riener, M. O. and Fritzsche, F. R. and Soll, C. and Pestalozzi, B. C. and Probst-Hensch N., and Clavien, P. A. and Jochum, W. and Soltermann, A. and Moch, H. and Kristiansen, G.. (2010) Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology, Vol. 56, H. 5. pp. 600-606.

Probst-Hensch N. M., and Steiner, J. H. and Schraml, P. and Varga, Z. and Zurrer-Hardi U., and Storz, M. and Korol, D. and Fehr, M. K. and Fink, D. and Pestalozzi, B. C. and Lutolf, U. M. and Theurillat, J. P. and Moch, H.. (2010) IGFBP2 and IGFBP3 protein expressions in human breast cancer : association with hormonal factors and obesity. Clinical cancer research, Vol. 16, no. 3. pp. 1025-1032.

Matter-Walstra, K. W. and Dedes, K. J. and Schwenkglenks, M. and Brauchli, P. and Szucs, T. D. and Pestalozzi, B. C.. (2010) Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21 (11). pp. 2161-2168.

2009

Riener, M. O. and Stenner, F. and Liewen, H. and Soll, C. and Breitenstein, S. and Pestalozzi, B. C. and Samaras, P. and Probst-Hensch N., and Hellerbrand, C. and Mullhaupt, B. and Clavien, P. A. and Bahra, M. and Neuhaus, P. and Wild, P. and Fritzsche, F. and Moch, H. and Jochum, W. and Kristiansen, G.. (2009) Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology : official journal of the American Association for the Study of Liver Diseases, Vol. 49, No. 5. pp. 1602-1609.

Riener, M. O. and Fritzsche, F. R. and Clavien, P. A. and Pestalozzi, B. C. and Probst-Hensch N., and Jochum, W. and Kristiansen, G.. (2009) IMP3 expression in lesions of the biliary tract : a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. Human pathology : a clinicopathologic quarterly, Vol. 40, H. 10. pp. 1377-1383.

Ruhstaller, T. and Widmer, L. and Schuller, J. C. and Roth, A. and Hess, V. and Mingrone, W. and von Moos, R. and Borner, M. and Pestalozzi, B. C. and Balmermajno, S. and Köberle, D. and Terraciano, L. and Schnider, A. and Bodis, S. and Popescu, R.. (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. pp. 1522-1528.

2008

Bernhard, J. and Dietrich, D. and Scheithauer, W. and Gerber, D. and Bodoky, G. and Ruhstaller, T. and Glimelius, B. and Bajetta, E. and Schüller, J. and Saletti, P. and Bauer, J. and Figer, A. and Pestalozzi, B. C. and Köhne, C. H. and Mingrone, W. and Stemmer, S. M. and Tàmas, K. and Kornek, G. V. and Koeberle, D. and Herrmann, R. and Central, European Cooperative Oncology Group. (2008) Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone : a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, Vol. 26. pp. 3695-3701.